Fractional Radiofrequency and Oral Isotretinoin—A Prospective Randomized Controlled Split‐Face Trial Comparing Concurrent Versus Delayed Fractional Radiofrequency Treatment for Acne Scars

Elisa S. Gallo,Uriel Katz,Ofir Artzi
DOI: https://doi.org/10.1002/lsm.23811
2024-06-20
Lasers in Surgery and Medicine
Abstract:Background Therapeutic dogma has been to treat acne scars no less than 6 months after isotretinoin (ITN) cessation. Objective To evaluate the safety and efficacy of fractional radiofrequency (FRF) in patients treated concurrently with ITN. Methods We conducted a prospective randomized control 3‐arm comparative trial to evaluate the treatment of acne scars. Patients received one of three treatment options: (A) ITN and FRF concurrent treatment, (B) ITN monotherapy, and (C) FRF 6 months post‐ITN treatment. Patients in the FRF cohorts received three monthly sessions. Patients were followed for adverse effects up to 6–9 months post‐FRF treatment. Final cosmesis was scored by three independent dermatologists using two scales: the Echelle d'Evaluation Clinique des Cicatrices d'Acne (ECCA) and an internal 5‐point investigator's scale, indicating the percentage of improvement. Subjective analyses by patients were also assessed. Results Objective and subjective analyses revealed improvement in the ITN‐FRF cohort, which was superior to the delayed FRF cohort and the ITN monotherapy cohort. Specifically, the concurrently treated cohort (ITN‐FRF) had a significant reduction in acne scar volume from baseline mean (151.1 ± 44.7 to 97.0 ± 31.2, p
dermatology,surgery
What problem does this paper attempt to address?